Compounds > amikacin
Page last updated: 2024-08-23

amikacin and tedizolid

amikacin has been researched along with tedizolid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D1
Ader, F; Dumitrescu, O; Hodille, E; Labussière-Wallet, H; Lebeaux, D; Morelec, I; Roux, S; Soueges, S; Triffault-Fillit, C1

Other Studies

2 other study(ies) available for amikacin and tedizolid

ArticleYear
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline

2018
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liposomes; Male; Middle Aged; Nebulizers and Vaporizers; Nocardia; Nocardia Infections; Oxazolidinones; Tetrazoles; Time Factors

2021